BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imani Fooladi AA, Mahmoodzadeh Hosseini H, Nourani MR, Khani S, Alavian SM. Probiotic as a novel treatment strategy against liver disease. Hepat Mon. 2013;13:e7521. [PMID: 23610585 DOI: 10.5812/hepatmon.7521] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in Glutathione Content in Liver Diseases: An Update. Antioxidants (Basel) 2021;10:364. [PMID: 33670839 DOI: 10.3390/antiox10030364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
2 Guan YS, He Q. A current update on the rule of alternative and complementary medicine in the treatment of liver diseases. Evid Based Complement Alternat Med 2013;2013:321234. [PMID: 24109491 DOI: 10.1155/2013/321234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Hu X, Zhang H, Lu H, Qian G, Lv L, Zhang C, Guo J, Jiang H, Zheng B, Yang F, Gu S, Chen Y, Bao Q, Yu L, Jiang X, Hu Q, Shi H, Gao H, Li L. The Effect of Probiotic Treatment on Patients Infected with the H7N9 Influenza Virus. PLoS One 2016;11:e0151976. [PMID: 26987119 DOI: 10.1371/journal.pone.0151976] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
4 Mohamadkhani A. On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B. Cancer Med. 2018;. [PMID: 29761927 DOI: 10.1002/cam4.1550] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
5 Ramos-tovar E, Muriel P. Does Nutrition Matter in Liver Disease? Liver Pathophysiology. Elsevier; 2017. pp. 743-59. [DOI: 10.1016/b978-0-12-804274-8.00053-9] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Tao X, Wang N, Qin W. Gut Microbiota and Hepatocellular Carcinoma. Gastrointest Tumors. 2015;2:33-40. [PMID: 26673641 DOI: 10.1159/000380895] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
7 De Filippis A, Ullah H, Baldi A, Dacrema M, Esposito C, Garzarella EU, Santarcangelo C, Tantipongpiradet A, Daglia M. Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment. Int J Mol Sci 2020;21:E4929. [PMID: 32668581 DOI: 10.3390/ijms21144929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
8 Jantararussamee C, Rodniem S, Taweechotipatr M, Showpittapornchai U, Pradidarcheep W. Hepatoprotective Effect of Probiotic Lactic Acid Bacteria on Thioacetamide-Induced Liver Fibrosis in Rats. Probiotics Antimicrob Proteins 2021;13:40-50. [PMID: 32468435 DOI: 10.1007/s12602-020-09663-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Saeedi P, Salimian J, Ahmadi A, Imani Fooladi AA. The transient but not resident (TBNR) microbiome: a Yin Yang model for lung immune system. Inhal Toxicol 2015;27:451-61. [PMID: 26307905 DOI: 10.3109/08958378.2015.1070220] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
10 Wang Y, Xie J, Li Y, Dong S, Liu H, Chen J, Wang Y, Zhao S, Zhang Y, Zhang H. Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure. Eur J Nutr 2016;55:821-31. [PMID: 25893720 DOI: 10.1007/s00394-015-0904-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
11 Aziz Mousavi SMA, Mirhosseini SA, Rastegar Shariat Panahi M, Mahmoodzadeh Hosseini H. Characterization of Biosynthesized Silver Nanoparticles Using Lactobacillus rhamnosus GG and its In Vitro Assessment Against Colorectal Cancer Cells. Probiotics Antimicrob Proteins 2020;12:740-6. [PMID: 31020619 DOI: 10.1007/s12602-019-09530-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
12 Elzouki AN. Probiotics and Liver Disease: Where Are We Now and Where Are We Going? J Clin Gastroenterol. 2016;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & amp; New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S188-S190. [PMID: 27741172 DOI: 10.1097/mcg.0000000000000712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Zeng T, Zhang CL, Xiao M, Yang R, Xie KQ. Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical Trials. Front Immunol 2016;7:538. [PMID: 27965666 DOI: 10.3389/fimmu.2016.00538] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
14 Chávez-tapia NC, González-rodríguez L, Jeong M, López-ramírez Y, Barbero-becerra V, Juárez-hernández E, Romero-flores JL, Arrese M, Méndez-sánchez N, Uribe M. Current evidence on the use of probiotics in liver diseases. Journal of Functional Foods 2015;17:137-51. [DOI: 10.1016/j.jff.2015.05.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
15 Dalal R, McGee RG, Riordan SM, Webster AC. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;2:CD008716. [PMID: 28230908 DOI: 10.1002/14651858.cd008716.pub3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
16 Karamese M, Aydin H, Gelen V, Sengul E, Karamese SA. The anti-inflammatory, anti-oxidant and protective effects of a probiotic mixture on organ toxicity in a rat model. Future Microbiol 2020;15:401-12. [PMID: 32250184 DOI: 10.2217/fmb-2020-0005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 Dubey V, Ghosh AR, Bishayee K, Khuda-Bukhsh AR. Probiotic Pediococcus pentosaceus strain GS4 alleviates azoxymethane-induced toxicity in mice. Nutr Res 2015;35:921-9. [PMID: 26319614 DOI: 10.1016/j.nutres.2015.08.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
18 Andrejčáková Z, Sopková D, Vlčková R, Kulichová L, Gancarčíková S, Almášiová V, Holovská K, Petrilla V, Krešáková L. Synbiotics suppress the release of lactate dehydrogenase, promote non-specific immunity and integrity of jejunum mucosa in piglets. Anim Sci J 2016;87:1157-66. [PMID: 27581561 DOI: 10.1111/asj.12558] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
19 Fan Y, Xiong W, Li J, Hu A, He Z, Zhang J, Zhou G, Yin Q. Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus. Pharm Biol 2018;56:567-72. [PMID: 30460863 DOI: 10.1080/13880209.2018.1504972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Moein M, Imani Fooladi AA, Mahmoodzadeh Hosseini H. Determining the effects of green chemistry synthesized Ag-nisin nanoparticle on macrophage cells. Microb Pathog 2018;114:414-9. [PMID: 29241764 DOI: 10.1016/j.micpath.2017.12.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
21 Ahmadi S, Ghollasi M, Hosseini HM. The apoptotic impact of nisin as a potent bacteriocin on the colon cancer cells. Microbial Pathogenesis 2017;111:193-7. [DOI: 10.1016/j.micpath.2017.08.037] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
22 Bubnov RV, Spivak MY, Lazarenko LM, Bomba A, Boyko NV. Probiotics and immunity: provisional role for personalized diets and disease prevention. EPMA J 2015;6:14. [PMID: 26221192 DOI: 10.1186/s13167-015-0036-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
23 Sato K, Meng F, Fava G, Glaser S, Alpini G. Functional roles of gut bacteria imbalance in cholangiopathies. Liver Research 2019;3:40-5. [DOI: 10.1016/j.livres.2018.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
24 Yefimenko OY, Savchenko YO, Falalyeyeva TM, Beregova TV, Zholobak NM, Spivak MY, Shcherbakov OB, Bubnov RV. Nanocrystalline cerium dioxide efficacy for gastrointestinal motility: potential for prokinetic treatment and prevention in elderly. EPMA J 2015;6:6. [PMID: 25815090 DOI: 10.1186/s13167-015-0029-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
25 Li F, Duan K, Wang C, McClain C, Feng W. Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterol Res Pract 2016;2016:5491465. [PMID: 26839540 DOI: 10.1155/2016/5491465] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
26 Gao X, Zhu Y, Wen Y, Liu G, Wan C. Efficacy of probiotics in non-alcoholic fatty liver disease in adult and children: A meta-analysis of randomized controlled trials. Hepatol Res 2016;46:1226-33. [PMID: 26866817 DOI: 10.1111/hepr.12671] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
27 Oo KM, Lwin AA, Kyaw YY, Tun WM, Fukada K, Goshima A, Shimada T, Okada S. Safety and long-term effect of the probiotic FK-23 in patients with hepatitis C virus infection. Biosci Microbiota Food Health 2016;35:123-8. [PMID: 27508113 DOI: 10.12938/bmfh.2015-024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
28 Laborda TJ, Jensen MK, Kavan M, Deneau M. Treatment of primary sclerosing cholangitis in children. World J Hepatol 2019; 11(1): 19-36 [PMID: 30705716 DOI: 10.4254/wjh.v11.i1.19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
29 王蓉, 宋明宇, 李学文, 杜鹏, 杨玲. 肠道菌群改变与肝纤维化相互作用的研究进展. 世界华人消化杂志 2014; 22(26): 3937-3940 [DOI: 10.11569/wcjd.v22.i26.3937] [Reference Citation Analysis]
30 Asgharian A, Askari G, Esmailzade A, Feizi A, Mohammadi V. The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical Trial. Int J Prev Med 2016;7:59. [PMID: 27076897 DOI: 10.4103/2008-7802.178533] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
31 Fang TJ, Guo JT, Lin MK, Lee MS, Chen YL, Lin WH. Protective effects of Lactobacillus plantarum against chronic alcohol-induced liver injury in the murine model. Appl Microbiol Biotechnol 2019;103:8597-608. [PMID: 31515596 DOI: 10.1007/s00253-019-10122-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Bouhafs L, Moudilou EN, Exbrayat JM, Lahouel M, Idoui T. Protective effects of probiotic Lactobacillus plantarum BJ0021 on liver and kidney oxidative stress and apoptosis induced by endosulfan in pregnant rats. Renal Failure 2015;37:1370-8. [DOI: 10.3109/0886022x.2015.1073543] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
33 Jin YY, Singh P, Chung HJ, Hong ST. Blood Ammonia as a Possible Etiological Agent for Alzheimer's Disease. Nutrients 2018;10:E564. [PMID: 29734664 DOI: 10.3390/nu10050564] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
34 Madsen BS, Havelund T, Krag A. Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers. Adv Ther 2013;30:659-70. [PMID: 23881723 DOI: 10.1007/s12325-013-0044-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
35 Vasco M, Paolillo R, Schiano C, Sommese L, Cuomo O, Napoli C. Compromised nutritional status in patients with end-stage liver disease: Role of gut microbiota. Hepatobiliary Pancreat Dis Int 2018;17:290-300. [PMID: 30173786 DOI: 10.1016/j.hbpd.2018.06.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wan MLY, El-Nezami H. Targeting gut microbiota in hepatocellular carcinoma: Probiotics as a novel therapy. Hepatobiliary Surg Nutr. 2018;7:11-20. [PMID: 29531939 DOI: 10.21037/hbsn.2017.12.07] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]